Small molecule, big potential for treating prostate cancer

MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.

Bendta Schroeder | Koch Institute • mit
Nov. 19, 2020 ~9 min

medicine cancer research drug-development school-of-engineering national-institutes-of-health-nih biological-engineering koch-institute

SMART researchers develop gelatin microcarrier for cell production

Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers.

Singapore-MIT Alliance for Research and Technology • mit
Nov. 17, 2020 ~6 min

medicine cancer biology research cells school-of-engineering materials-science-and-engineering dmse biological-engineering bioengineering-and-biotechnology singapore-mit-alliance-for-research-and-technology-smart

Covid-19 “super-spreading” events play outsized role in overall disease transmission

Mathematical analysis suggests that preventing large gatherings could significantly reduce Covid-19 infection rates.

Anne Trafton | MIT News Office • mit
Nov. 2, 2020 ~6 min

public-health covid-19 pandemic research school-of-engineering biological-engineering institute-for-medical-engineering-and-science-imes

Silencing gene expression to cure complex diseases

Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.

Zach Winn | MIT News Office • mit
Oct. 26, 2020 ~9 min

health medicine genetics cancer startups biology rna alzheimers data disease research drug-development school-of-engineering innovation-and-entrepreneurship-ie alumniae biological-engineering

To make mini-organs grow faster, give them a squeeze

Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.

Jennifer Chu | MIT News Office • mit
Oct. 13, 2020 ~7 min

genetics cancer biology research cells mechanical-engineering school-of-engineering biological-engineering

Cancer researchers collaborate, target DNA damage repair pathways for cancer therapy

MIT researchers find blocking the expressions of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.

Koch Institute • mit
Oct. 1, 2020 ~7 min

chemistry medicine cancer research school-of-engineering school-of-science biological-engineering koch-institute chemical-engineering